Page last updated: 2024-11-05

2-hydroxyphenylacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Hydroxyphenylacetic acid, also known as o-hydroxyphenylacetic acid, is a naturally occurring organic compound found in various plants. It is a phenolic acid derivative of acetic acid. The compound is synthesized in plants via the shikimate pathway. 2-hydroxyphenylacetic acid exhibits diverse biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties. Research suggests it may have potential therapeutic applications in conditions such as cancer, diabetes, and neurodegenerative diseases. Its role in plant defense mechanisms and its potential as a precursor for the synthesis of other bioactive compounds make it an interesting subject of study.'

2-hydroxyphenylacetic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(2-hydroxyphenyl)acetic acid : A hydroxy monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 2-hydroxyphenyl group. It is a metabolite of phenylalanine and is excreted in the urine of patients suffering from diseases like phenylketonuria. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11970
CHEMBL ID240714
CHEBI ID28478
SCHEMBL ID72309
MeSH IDM0047512

Synonyms (67)

Synonym
AC-2695
unii-uk3r9q59av
uk3r9q59av ,
o-hydroxy phenylacetic acid
nsc 62000
einecs 210-393-2
hydroxyphenylacetic acid
STL301502
ohp ,
2-hydroxybenzeneacetic acid
(o-hydroxyphenyl)acetic acid
nsc62000
acetic acid, (o-hydroxyphenyl)-
nsc-62000
o-hydroxyphenylacetic acid
benzeneacetic acid, 2-hydroxy-
inchi=1/c8h8o3/c9-7-4-2-1-3-6(7)5-8(10)11/h1-4,9h,5h2,(h,10,11
(2-hydroxyphenyl)-acetic acid
(2-hydroxyphenyl)acetic acid
C05852
2-hydroxyphenylacetate
2-hydroxyphenylacetic acid
614-75-5
2-hydroxyphenylacetic acid, reagentplus(r), 99%
chembl240714 ,
bdbm16426
2-(2-hydroxyphenyl)acetic acid
H-7080
(o-hydroxyphenyl)acetate
acetic acid, 2-hydroxyphenyl-
7C10F5F6-7BF6-48EE-85EE-22D3FA4D62B1
chebi:28478 ,
BMSE000715
2'-hydroxyphenylacetic acid
H0340
AKOS004909470
2-hydroxy-benzeneaceticaci;2-hydroxyphenylacetate
A26509
EN300-50865
BP-13099
FT-0612632
FS-2587
AM20060692
hydroxyphenylacetic acid, o-
S6154
SCHEMBL72309
2-hydroxyphenylaceticacid
DTXSID1060633
2-hydroxy phenylacetic acid
2-hydroxy-benzeneacetic acid
2-hydroxy-phenylacetic acid
(2-hydroxy-phenyl)-acetic acid
2-(hydroxyphenyl)acetic acid
ortho-hydroxyphenylacetic acid
hydroxyphenylacetate
mfcd00004323
2-hydroxyphenylacetic acid, vetec(tm) reagent grade, 98%
2-hydroxybenzeneacetate
(o-hydroxyphenyl)-acetate
(o-hydroxyphenyl)-acetic acid
2-hpaa
HY-W015590
CS-W016306
2-hydroxyphenyl acetic acid
Q27103728
Z608061328
PD099467

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" For human physiologically based pharmacokinetic (PBPK) modeling, the metabolic ratios to o-hydroxyphenylacetic acid and 7-hydroxycoumarin were set at minor (0."( Metabolic profiles of coumarin in human plasma extrapolated from a rat data set with a simplified physiologically based pharmacokinetic model.
Hina, S; Kamiya, Y; Kobayashi, Y; Miura, T; Murayama, N; Shimizu, M; Yamazaki, H, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
hydroxy monocarboxylic acidAny monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Calcium/calmodulin-dependent protein kinase type II subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)0.00210.00010.71098.4000AID1909935
Calcium/calmodulin-dependent protein kinase type II subunit alphaRattus norvegicus (Norway rat)Ki1.99530.02201.47405.1000AID1909935
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)3.50000.00101.191310.0000AID309933
Aldo-keto reductase family 1 member B1Homo sapiens (human)Ki17.86670.01903.41939.3000AID1797503
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytosolCalcium/calmodulin-dependent protein kinase type II subunit alphaRattus norvegicus (Norway rat)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1449696Chaperone activity at recombinant human C-terminal FLAG-tagged pendrin P123S mutant expressed in HEK293 cells assessed as increase in localization of protein mutant in plasma membrane at 1 to 30 mM after 12 hrs by DAPI staining based immunofluorescence mi2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Discovery of (2-aminophenyl)methanol as a new molecular chaperone that rescues the localization of P123S mutant pendrin stably expressed in HEK293 cells.
AID1449688Cytotoxicity against HEK293 cells harboring pendrin P123S mutant after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Discovery of (2-aminophenyl)methanol as a new molecular chaperone that rescues the localization of P123S mutant pendrin stably expressed in HEK293 cells.
AID309933Inhibition of aldose reductase2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
AID1909935Inhibition of [3H]NCS-382 binding to CaMK2alpha in rat cerebrocortical membranes
AID498706Inhibition of beta lactamase CTX-M assessed as hydrolysis of beta lactam up to 5 mM by spectrometry analysis2009Nature chemical biology, May, Volume: 5, Issue:5
Molecular docking and ligand specificity in fragment-based inhibitor discovery.
AID1797503Enzyme Inhibition Assay from Article 10.1016/j.bioorg.2006.09.004: \\Structural and thermodynamic studies of simple aldose reductase-inhibitor complexes.\\2006Bioorganic chemistry, Dec, Volume: 34, Issue:6
Structural and thermodynamic studies of simple aldose reductase-inhibitor complexes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (9.38)18.7374
1990's9 (28.13)18.2507
2000's11 (34.38)29.6817
2010's6 (18.75)24.3611
2020's3 (9.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.43 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index41.24 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]